Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer

Despite standard-of-care treatment, more than 30% of patients with resectable colorectal cancer (CRC) relapse. Circulating tumor DNA (ctDNA) analysis may enable postsurgical risk stratification and adjuvant chemotherapy (ACT) treatment decision-making. We report results from GALAXY, which is an obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotani, Daisuke, Oki, Eiji, Nakamura, Yoshiaki, Yukami, Hiroki, Mishima, Saori, Bando, Hideaki, Shirasu, Hiromichi, Yamazaki, Kentaro, Watanabe, Jun, Kotaka, Masahito, Hirata, Keiji, Akazawa, Naoya, Kataoka, Kozo, Sharma, Shruti, Aushev, Vasily N., Aleshin, Alexey, Misumi, Toshihiro, Taniguchi, Hiroya, Takemasa, Ichiro, Kato, Takeshi, Mori, Masaki, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873552/
https://www.ncbi.nlm.nih.gov/pubmed/36646802
http://dx.doi.org/10.1038/s41591-022-02115-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873552/
https://www.ncbi.nlm.nih.gov/pubmed/36646802
http://dx.doi.org/10.1038/s41591-022-02115-4

Ejemplares similares